Breast Cancer: Metastasis, Molecular Subtypes, and Overweight and Obesity in Veracruz, Mexico

Barrera-Cruz, 2013, Escenario actual de la obesidad en México, Rev Med Inst Mex Seguro Soc, 51, 292 Dávila-Torres, 2015, Panorama de la obesidad en México, Rev Med Inst Mex Seguro Soc, 53, 240 Greenlee, 2016, Trends in obesity prevalence in adults with a history of cancer: results from the US National Health Interview Survey, 1997 to 2014, J Clin Oncol, 34, 3133, 10.1200/JCO.2016.66.4391 Carey, 2006, Race, breast cancer subtypes, and survival in the Carolina Breast Cancer Study, JAMA, 295, 2492, 10.1001/jama.295.21.2492 Chan, 2014, Body mass index and survival in women with breast cancer—systematic literature review and meta-analysis of 82 follow-up studies, Ann Oncol, 42, 212 Azrad, 2014, The association between adiposity and breast cancer recurrence and survival: a review of the recent literature, Curr Nutr Rep, 3, 9, 10.1007/s13668-013-0068-9 Connor, 2013, Obesity and risk of breast cancer mortality in Hispanic and non-Hispanic white women: the New Mexico Women's Health Study, J Womens Health, 22, 368, 10.1089/jwh.2012.4191 Hsieh, 1990, Age at menarche, age at menopause, height and obesity as risk factors for breast cancer: associations and interactions in an international case-control study, Int J Cancer, 46, 796, 10.1002/ijc.2910460508 Navarro-Ibarra, 2015, Influencia de los factores reproductivos, la lactancia materna y la obesidad sobre el riesgo de cáncer de mama en mujeres mexicanas, Nutr Hosp, 32, 291 Suba, 2013, Circulatory estrogen level protects against breast cancer in obese women, Recent Pat Anticancer Drug Discov, 8, 154, 10.2174/1574892811308020004 Drew, 2015, Estrogen receptor (ER) α-regulated lipocalin 2 expression in adipose tissue links obesity with breast cancer progression, J Biol Chem, 290, 5566, 10.1074/jbc.M114.606459 Chen, 2016, Reproductive factors and risk of luminal, HER2-overexpressing and triple negative breast cancer among multiethnic women, Cancer Epidemiol Biomarkers Prev, 25, 1297, 10.1158/1055-9965.EPI-15-1104 Howlader, 2014, US incidence of breast cancer subtypes defined by joint hormone receptor and HER2 status, J Natl Cancer Inst, 106, dju055, 10.1093/jnci/dju055 Wacker, 2009, Ethnicity, body size, and estrogen levels in postmenopausal Hispanic and non-Hispanic white women, J Womens Health, 18, 487, 10.1089/jwh.2008.0835 Phipps, 2008, Body size and risk of luminal, HER2-overexpressing, and triple-negative breast cancer in postmenopausal women, Cancer Epidemiol Biomarkers Prev, 17, 2078, 10.1158/1055-9965.EPI-08-0206 Chen, 2016, Body mass index and risk of luminal, HER2-overexpressing, and triple negative breast cancer, Breast Cancer Res Treat, 157, 545, 10.1007/s10549-016-3825-9 Li, 2017, BMI, reproductive factors, and breast cancer molecular subtypes: a case-control study and meta-analysis, J Epidemiol, 27, 143 World Health Organization Fact sheet: obesity and overweight. Available at: http://www.who.int/en/news-room/fact-sheets/detail/obesity-and-overweight. Accessed May 15, 2017. Cárdenas-Sánchez, 2015, Consenso Mexicano sobre diagnóstico y tratamiento del cáncer mamario, Gaceta Mexicana de Oncología, 14, 2 Kaviani, 2013, Effects of obesity on presentation of breast cancer, lymph node metastasis and patient survival: a retrospective review, Asian Pac J Cancer Prev, 14, 2225, 10.7314/APJCP.2013.14.4.2225 Keskin, 2013, Impact of the obesity on lymph node status in operable breast cancer patients, J BUON, 18, 824 Lee, 2014, Reproductive factors and subtypes of breast cancer defined by estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2: a register-based study from Korea, Clin Breast Cancer, 14, 426, 10.1016/j.clbc.2014.05.003 Osman, 2015, Obesity correlation with metastases development and response to first-line metastatic chemotherapy in breast cancer, Clin Med Insights Oncol, 9, 105, 10.4137/CMO.S32812 Scholz, 2015, Obesity as an independent risk factor for decreased survival in node-positive high-risk breast cancer, Breast Cancer Res Treat, 151, 569, 10.1007/s10549-015-3422-3 Morimoto, 2002, Obesity, body size, and risk of postmenopausal breast cancer: the Women's Health Initiative (United States), Cancer Causes Control, 13, 741, 10.1023/A:1020239211145 Agresti, 2016, Association of adiposity, dysmetabolisms, and inflammation with aggressive breast cancer subtypes: a cross-sectional study, Breast Cancer Res Treat, 157, 179, 10.1007/s10549-016-3802-3 John, 2018, Reproductive history, breast-feeding and risk of triple negative breast cancer: the Breast Cancer Etiology in Minorities (BEM) study, Int J Cancer, 142, 2273, 10.1002/ijc.31258 Albrektsen, 2005, Breast cancer risk by age at birth, time since birth and time intervals between births: exploring interaction effects, Br J Cancer, 92, 167, 10.1038/sj.bjc.6602302 Anderson, 2014, Reproductive risk factors and breast cancer subtypes: a review of the literature, Breast Cancer Res Treat, 144, 1, 10.1007/s10549-014-2852-7 De Bruijn, 2013, Systematic review and meta-analysis of the association between diabetes mellitus and incidence and mortality in breast and colorectal cancer, Br J Surg, 100, 1421, 10.1002/bjs.9229 Rose, 2015, The interactions of obesity, inflammation and insulin resistance in breast cancer, Cancer, 7, 2147, 10.3390/cancers7040883 Westley, 2013, A twenty-first century cancer epidemic caused by obesity: the involvement of insulin, diabetes, and insulin-like growth factors, Int J Endocrinol, 2013, 1, 10.1155/2013/632461